Mind Medicine (MindMed) (OTCMKTS:MMEDF) Shares Down 0.7% – Time to Sell?

Posted by on Mar 21st, 2025

Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price dropped 0.7% on Friday . The company traded as low as $6.53 and last traded at $6.65. Approximately 680,630 shares traded hands during trading, a decline of 80% from the average daily volume of 3,376,665 shares. The stock had previously closed at $6.70.

Mind Medicine (MindMed) Stock Performance

The stock’s 50-day moving average is $7.29 and its two-hundred day moving average is $6.93.

About Mind Medicine (MindMed)

(Get Free Report)

Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.

Featured Stories

Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.